However, Sato et al. suggested that TM5275 (a small molecular inhibitor of PAI-1) can increase the collagenase activity of SiHa and CaSki cells (Sato et al. 2016), implying that lower expression of PAI-1 benefits the ECM degration and cervical cancer migration. Here, SERPINE1 is linked to cervical cancer.